Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1.5 29 32 29 32 B-lower_bound
K 33 34 33 34 I-lower_bound
/ 34 35 34 35 I-lower_bound
cu 35 37 35 37 I-lower_bound
mm 38 40 38 40 I-lower_bound

Abutment 0 8 41 49 O
of 9 11 50 52 O
the 12 15 53 56 O
SMA 16 19 57 60 B-clinical_variable
> 20 21 61 62 O
= 21 22 62 63 O
180 23 26 64 67 B-lower_bound
degrees 27 34 68 75 I-lower_bound

Abutment 0 8 76 84 B-clinical_variable
of 9 11 85 87 I-clinical_variable
the 12 15 88 91 I-clinical_variable
SMV 16 19 92 95 I-clinical_variable
or 20 22 96 98 O
PV 23 25 99 101 B-clinical_variable
> 26 27 102 103 O
= 27 28 103 104 O
180 29 32 105 108 B-lower_bound
degrees 33 40 109 116 I-lower_bound

Abutment 0 8 117 125 O
of 9 11 126 128 O
the 12 15 129 132 O
superior 16 24 133 141 B-clinical_variable
mesenteric 25 35 142 152 I-clinical_variable
artery 36 42 153 159 I-clinical_variable
( 43 44 160 161 I-clinical_variable
SMA 44 47 161 164 I-clinical_variable
) 47 48 164 165 I-clinical_variable
< 49 50 166 167 O
180 51 54 168 171 B-upper_bound
degrees 55 62 172 179 I-upper_bound

Active 0 6 180 186 B-chronic_disease
infection 7 16 187 196 I-chronic_disease
requiring 17 26 197 206 O
intravenous 27 38 207 218 O
antibiotics 39 50 219 230 B-treatment
at 51 53 231 233 O
the 54 57 234 237 O
time 58 62 238 242 O
of 63 65 243 245 O
registration 66 78 246 258 O

Any 0 3 259 262 O
prior 4 9 263 268 B-treatment
therapy 10 17 269 276 I-treatment
( 18 19 277 278 O
chemotherapy 19 31 278 290 B-treatment
, 31 32 290 291 O
radiation 33 42 292 301 B-treatment
or 43 45 302 304 O
surgery 46 53 305 312 B-treatment
) 53 54 312 313 O
for 55 58 314 317 O
pancreatic 59 69 318 328 B-cancer
adenocarcinoma 70 84 329 343 I-cancer
other 85 90 344 349 O
than 91 95 350 354 O
biliary 96 103 355 362 B-treatment
decompression 104 117 363 376 I-treatment

Aspartate 0 9 377 386 B-clinical_variable
aminotransferase 10 26 387 403 I-clinical_variable
( 27 28 404 405 I-clinical_variable
AST 28 31 405 408 I-clinical_variable
) 31 32 408 409 I-clinical_variable
( 33 34 410 411 O
serum 34 39 411 416 B-clinical_variable
glutamic 40 48 417 425 I-clinical_variable
oxaloacetic 49 60 426 437 I-clinical_variable
transaminase 61 73 438 450 I-clinical_variable
[ 74 75 451 452 I-clinical_variable
SGOT])/alanine 75 89 452 466 I-clinical_variable
aminotransferase 90 106 467 483 I-clinical_variable
( 107 108 484 485 I-clinical_variable
ALT 108 111 485 488 I-clinical_variable
) 111 112 488 489 I-clinical_variable
( 113 114 490 491 O
serum 114 119 491 496 B-clinical_variable
glutamate 120 129 497 506 I-clinical_variable
pyruvate 130 138 507 515 I-clinical_variable
transaminase 139 151 516 528 I-clinical_variable
[ 152 153 529 530 I-clinical_variable
SGPT 153 157 530 534 I-clinical_variable
] 157 158 534 535 I-clinical_variable
) 158 159 535 536 O
= 160 161 537 538 O
< 161 162 538 539 O
2.5 163 166 540 543 B-upper_bound
x 167 168 544 545 I-upper_bound
institutional 169 182 546 559 I-upper_bound
upper 183 188 560 565 I-upper_bound
limit 189 194 566 571 I-upper_bound
of 195 197 572 574 I-upper_bound
normal 198 204 575 581 I-upper_bound

Creatinine 0 10 582 592 B-clinical_variable
within 11 17 593 599 O
normal 18 24 600 606 O
institutional 25 38 607 620 O
limits 39 45 621 627 O
or 46 48 628 630 O
creatinine 49 59 631 641 B-clinical_variable
clearance 60 69 642 651 I-clinical_variable
> 70 71 652 653 O
= 71 72 653 654 O
60 73 75 655 657 B-lower_bound
mL 76 78 658 660 I-lower_bound
/ 78 79 660 661 I-lower_bound
min 79 82 661 664 I-lower_bound

Eastern 0 7 665 672 B-clinical_variable
Cooperative 8 19 673 684 I-clinical_variable
Oncology 20 28 685 693 I-clinical_variable
Group 29 34 694 699 I-clinical_variable
( 35 36 700 701 I-clinical_variable
ECOG 36 40 701 705 I-clinical_variable
) 40 41 705 706 I-clinical_variable
performance 42 53 707 718 I-clinical_variable
status 54 60 719 725 I-clinical_variable
= 61 62 726 727 O
< 62 63 727 728 O
1 64 65 729 730 B-upper_bound

Hemoglobin 0 10 731 741 B-clinical_variable
> 11 12 742 743 O
= 12 13 743 744 O
9.0 14 17 745 748 B-lower_bound
g 18 19 749 750 I-lower_bound
/ 19 20 750 751 I-lower_bound
dL 20 22 751 753 I-lower_bound

History 0 7 754 761 O
of 8 10 762 764 O
allergic 11 19 765 773 O
reactions 20 29 774 783 O
attributed 30 40 784 794 O
to 41 43 795 797 O
compounds 44 53 798 807 O
of 54 56 808 810 O
similar 57 64 811 818 O
chemical 65 73 819 827 O
or 74 76 828 830 O
biologic 77 85 831 839 O
composition 86 97 840 851 O
to 98 100 852 854 O
ABRAXANE 101 109 855 863 B-chronic_disease
or 110 112 864 866 O
other 113 118 867 872 O
agents 119 125 873 879 O
used 126 130 880 884 O
in 131 133 885 887 O
the 134 137 888 891 O
study 138 143 892 897 O

History 0 7 898 905 O
of 8 10 906 908 O
interstitial 11 23 909 921 B-chronic_disease
lung 24 28 922 926 I-chronic_disease
disease 29 36 927 934 I-chronic_disease
, 36 37 934 935 O
idiopathic 38 48 936 946 B-chronic_disease
pulmonary 49 58 947 956 I-chronic_disease
fibrosis 59 67 957 965 I-chronic_disease
, 67 68 965 966 O
silicosis 69 78 967 976 B-chronic_disease
, 78 79 976 977 O
sarcoidosis 80 91 978 989 B-chronic_disease
or 92 94 990 992 O
connective 95 105 993 1003 B-chronic_disease
tissue 106 112 1004 1010 I-chronic_disease
disorders 113 122 1011 1020 I-chronic_disease
( 123 124 1021 1022 O
including 124 133 1022 1031 O
rheumatoid 134 144 1032 1042 B-chronic_disease
arthritis 145 154 1043 1052 I-chronic_disease
and 155 158 1053 1056 O
systemic 159 167 1057 1065 B-chronic_disease
lupus 168 173 1066 1071 I-chronic_disease
erythematosus 174 187 1072 1085 I-chronic_disease
) 187 188 1085 1086 O

No 0 2 1087 1089 O
baseline 3 11 1090 1098 O
peripheral 12 22 1099 1109 B-chronic_disease
sensory 23 30 1110 1117 I-chronic_disease
neuropathy 31 41 1118 1128 I-chronic_disease
> 42 43 1129 1130 O
= 43 44 1130 1131 O
grade 45 50 1132 1137 B-lower_bound
2 51 52 1138 1139 I-lower_bound

No 0 2 1140 1142 O
prior 3 8 1143 1148 B-treatment
therapy 9 16 1149 1156 I-treatment
for 17 20 1157 1160 O
pancreatic 21 31 1161 1171 B-cancer
cancer 32 38 1172 1178 I-cancer
, 38 39 1178 1179 O
including 40 49 1180 1189 O
chemotherapy 50 62 1190 1202 B-treatment
, 62 63 1202 1203 O
radiation 64 73 1204 1213 B-treatment
therapy 74 81 1214 1221 I-treatment
, 81 82 1221 1222 O
definitive 83 93 1223 1233 O
surgery 94 101 1234 1241 B-treatment
or 102 104 1242 1244 O
investigational 105 120 1245 1260 B-treatment
therapy 121 128 1261 1268 I-treatment

Occlusion 0 9 1269 1278 O
of 10 12 1279 1281 O
the 13 16 1282 1285 O
SMV 17 20 1286 1289 B-chronic_disease
or 21 23 1290 1292 O
PV 24 26 1293 1295 B-chronic_disease
with 27 31 1296 1300 O
insufficient 32 44 1301 1313 O
normal 45 51 1314 1320 O
vein 52 56 1321 1325 O
above 57 62 1326 1331 O
and 63 66 1332 1335 O
below 67 72 1336 1341 O
with 73 77 1342 1346 O
which 78 83 1347 1352 O
to 84 86 1353 1355 O
perform 87 94 1356 1363 O
venous 95 101 1364 1370 B-treatment
reconstruction 102 116 1371 1385 I-treatment

Platelets 0 9 1386 1395 B-clinical_variable
> 10 11 1396 1397 O
= 11 12 1397 1398 O
100 13 16 1399 1402 B-lower_bound
K 17 18 1403 1404 I-lower_bound
/ 18 19 1404 1405 I-lower_bound
cu 19 21 1405 1407 I-lower_bound
mm 22 24 1408 1410 I-lower_bound

Pregnant 0 8 1411 1419 B-pregnancy

Short 0 5 1420 1425 O
- 5 6 1425 1426 O
segment 6 13 1426 1433 O
involvement 14 25 1434 1445 O
of 26 28 1446 1448 O
the 29 32 1449 1452 O
hepatic 33 40 1453 1460 O
artery 41 47 1461 1467 O
or 48 50 1468 1470 O
its 51 54 1471 1474 O
branches 55 63 1475 1483 O
amenable 64 72 1484 1492 O
to 73 75 1493 1495 O
resection 76 85 1496 1505 B-treatment
and 86 89 1506 1509 I-treatment
reconstruction 90 104 1510 1524 I-treatment

Short 0 5 1525 1530 O
- 5 6 1530 1531 O
segment 6 13 1531 1538 O
occlusion 14 23 1539 1548 O
of 24 26 1549 1551 O
the 27 30 1552 1555 O
SMV 31 34 1556 1559 O
or 35 37 1560 1562 O
PV 38 40 1563 1565 O
amenable 41 49 1566 1574 O
to 50 52 1575 1577 O
resection 53 62 1578 1587 B-treatment
and 63 66 1588 1591 O
venous 67 73 1592 1598 B-treatment
reconstruction 74 88 1599 1613 I-treatment

Subjects 0 8 1614 1622 O
known 9 14 1623 1628 O
to 15 17 1629 1631 O
be 18 20 1632 1634 O
human 21 26 1635 1640 B-chronic_disease
immunodeficiency 27 43 1641 1657 I-chronic_disease
virus 44 49 1658 1663 I-chronic_disease
( 50 51 1664 1665 I-chronic_disease
HIV)-positive 51 64 1665 1678 I-chronic_disease
, 64 65 1678 1679 O
including 66 75 1680 1689 O
those 76 81 1690 1695 O
on 82 84 1696 1698 O
combination 85 96 1699 1710 O
antiretroviral 97 111 1711 1725 B-treatment
therapy 112 119 1726 1733 I-treatment

Subjects 0 8 1734 1742 O
must 9 13 1743 1747 O
have 14 18 1748 1752 O
histologically 19 33 1753 1767 O
or 34 36 1768 1770 O
cytologically 37 50 1771 1784 O
confirmed 51 60 1785 1794 O
adenocarcinoma 61 75 1795 1809 B-cancer
of 76 78 1810 1812 I-cancer
the 79 82 1813 1816 I-cancer
pancreas 83 91 1817 1825 I-cancer

Subjects 0 8 1826 1834 O
must 9 13 1835 1839 O
have 14 18 1840 1844 O
measurable 19 29 1845 1855 O
disease 30 37 1856 1863 O
( 38 39 1864 1865 O
by 39 41 1865 1867 O
RECIST 42 48 1868 1874 O
1.1 49 52 1875 1878 O
) 52 53 1878 1879 O
, 53 54 1879 1880 O
defined 55 62 1881 1888 O
as 63 65 1889 1891 O
at 66 68 1892 1894 O
least 69 74 1895 1900 O
one 75 78 1901 1904 B-lower_bound
lesion 79 85 1905 1911 O
that 86 90 1912 1916 O
can 91 94 1917 1920 O
be 95 97 1921 1923 O
accurately 98 108 1924 1934 O
measured 109 117 1935 1943 O
in 118 120 1944 1946 O
at 121 123 1947 1949 O
least 124 129 1950 1955 O
one 130 133 1956 1959 O
dimension 134 143 1960 1969 B-clinical_variable
( 144 145 1970 1971 O
longest 145 152 1971 1978 O
diameter 153 161 1979 1987 B-clinical_variable
to 162 164 1988 1990 O
be 165 167 1991 1993 O
recorded 168 176 1994 2002 O
for 177 180 2003 2006 O
non 181 184 2007 2010 O
- 184 185 2010 2011 O
nodal 185 190 2011 2016 B-clinical_variable
lesions 191 198 2017 2024 I-clinical_variable
and 199 202 2025 2028 O
short 203 208 2029 2034 O
axis 209 213 2035 2039 O
for 214 217 2040 2043 O
nodal 218 223 2044 2049 O
lesions 224 231 2050 2057 O
) 231 232 2057 2058 O
as 233 235 2059 2061 O
> 236 237 2062 2063 O
= 237 238 2063 2064 O
20 239 241 2065 2067 B-lower_bound
mm 242 244 2068 2070 I-lower_bound
with 245 249 2071 2075 O
conventional 250 262 2076 2088 O
techniques 263 273 2089 2099 O
or 274 276 2100 2102 O
as 277 279 2103 2105 O
> 280 281 2106 2107 O
= 281 282 2107 2108 O
10 283 285 2109 2111 B-lower_bound
mm 286 288 2112 2114 I-lower_bound
with 289 293 2115 2119 O
spiral 294 300 2120 2126 B-treatment
CT 301 303 2127 2129 I-treatment
scan 304 308 2130 2134 I-treatment

Subjects 0 8 2135 2143 O
who 9 12 2144 2147 O
are 13 16 2148 2151 O
receiving 17 26 2152 2161 O
any 27 30 2162 2165 O
other 31 36 2166 2171 B-treatment
investigational 37 52 2172 2187 I-treatment
agents 53 59 2188 2194 I-treatment

Subjects 0 8 2195 2203 O
with 9 13 2204 2208 O
known 14 19 2209 2214 O
metastases 20 30 2215 2225 B-cancer

Subjects 0 8 2226 2234 O
with 9 13 2235 2239 O
locally 14 21 2240 2247 O
advanced 22 30 2248 2256 O
, 30 31 2256 2257 O
unresectable 32 44 2258 2270 O
primary 45 52 2271 2278 B-cancer
tumors 53 59 2279 2285 I-cancer

Total 0 5 2286 2291 B-clinical_variable
bilirubin 6 15 2292 2301 I-clinical_variable
= 16 17 2302 2303 O
< 17 18 2303 2304 O
1.25 19 23 2305 2309 B-upper_bound
x 24 25 2310 2311 I-upper_bound
upper 26 31 2312 2317 I-upper_bound
limit 32 37 2318 2323 I-upper_bound
of 38 40 2324 2326 I-upper_bound
normal 41 47 2327 2333 I-upper_bound
( 48 49 2334 2335 I-upper_bound
ULN 49 52 2335 2338 I-upper_bound
) 52 53 2338 2339 I-upper_bound

Tumor 0 5 2340 2345 B-cancer
- 5 6 2345 2346 O
associated 6 16 2346 2356 O
deformity 17 26 2357 2366 O
of 27 29 2367 2369 O
the 30 33 2370 2373 O
SMV 34 37 2374 2377 O
( 38 39 2378 2379 O
superior 39 47 2379 2387 O
mesenteric 48 58 2388 2398 O
vein 59 63 2399 2403 O
) 63 64 2403 2404 O
or 65 67 2405 2407 O
PV 68 70 2408 2410 O
( 71 72 2411 2412 O
portal 72 78 2412 2418 O
vein 79 83 2419 2423 O
) 83 84 2423 2424 O

Tumors 0 6 2425 2431 B-cancer
must 7 11 2432 2436 O
be 12 14 2437 2439 O
localized 15 24 2440 2449 O
( 25 26 2450 2451 O
non 26 29 2451 2454 O
- 29 30 2454 2455 O
metastatic 30 40 2455 2465 O
) 40 41 2465 2466 O
and 42 45 2467 2470 O
classified 46 56 2471 2481 O
as 57 59 2482 2484 O
borderline 60 70 2485 2495 O
resectable 71 81 2496 2506 O
according 82 91 2507 2516 O
to 92 94 2517 2519 O
Americas 95 103 2520 2528 O
Hepato 104 110 2529 2535 O
- 110 111 2535 2536 O
Pancreato 111 120 2536 2545 O
- 120 121 2545 2546 O
Biliary 121 128 2546 2553 O
Association 129 140 2554 2565 O
( 141 142 2566 2567 O
AHPBA)/Society 142 156 2567 2581 O
of 157 159 2582 2584 O
Surgical 160 168 2585 2593 O
Oncology 169 177 2594 2602 O
( 178 179 2603 2604 O
SSO)/Society 179 191 2604 2616 O
for 192 195 2617 2620 O
Surgery 196 203 2621 2628 O
of 204 206 2629 2631 O
the 207 210 2632 2635 O
Alimentary 211 221 2636 2646 O
Tract 222 227 2647 2652 O
( 228 229 2653 2654 O
SSAT 229 233 2654 2658 O
) 233 234 2658 2659 O
consensus 235 244 2660 2669 O
criteria 245 253 2670 2678 O
or 254 256 2679 2681 O
be 257 259 2682 2684 O
clinically 260 270 2685 2695 O
node 271 275 2696 2700 O
- 275 276 2700 2701 O
positive 276 284 2701 2709 O
via 285 288 2710 2713 O
computed 289 297 2714 2722 B-treatment
tomography 298 308 2723 2733 I-treatment
( 309 310 2734 2735 I-treatment
CT 310 312 2735 2737 I-treatment
) 312 313 2737 2738 I-treatment
or 314 316 2739 2741 O
endoscopic 317 327 2742 2752 B-treatment
ultrasound 328 338 2753 2763 I-treatment

Uncontrolled 0 12 2764 2776 O
intercurrent 13 25 2777 2789 O
illness 26 33 2790 2797 O
including 34 43 2798 2807 O
, 43 44 2807 2808 O
but 45 48 2809 2812 O
not 49 52 2813 2816 O
limited 53 60 2817 2824 O
to 61 63 2825 2827 O
, 63 64 2827 2828 O
ongoing 65 72 2829 2836 O
or 73 75 2837 2839 O
active 76 82 2840 2846 B-chronic_disease
infection 83 92 2847 2856 I-chronic_disease
, 92 93 2856 2857 O
symptomatic 94 105 2858 2869 O
congestive 106 116 2870 2880 B-chronic_disease
heart 117 122 2881 2886 I-chronic_disease
failure 123 130 2887 2894 I-chronic_disease
, 130 131 2894 2895 O
unstable 132 140 2896 2904 B-chronic_disease
angina 141 147 2905 2911 I-chronic_disease
pectoris 148 156 2912 2920 O
, 156 157 2920 2921 O
cardiac 158 165 2922 2929 B-chronic_disease
arrhythmia 166 176 2930 2940 I-chronic_disease
, 176 177 2940 2941 O
or 178 180 2942 2944 O
psychiatric 181 192 2945 2956 B-chronic_disease
illness 193 200 2957 2964 I-chronic_disease
/ 200 201 2964 2965 O
social 201 207 2965 2971 O
situations 208 218 2972 2982 O
that 219 223 2983 2987 O
would 224 229 2988 2993 O
limit 230 235 2994 2999 O
compliance 236 246 3000 3010 O
with 247 251 3011 3015 O
study 252 257 3016 3021 O
requirements 258 270 3022 3034 O

Women 0 5 3035 3040 B-gender
of 6 8 3041 3043 O
child 9 14 3044 3049 O
- 14 15 3049 3050 O
bearing 15 22 3050 3057 O
potential 23 32 3058 3067 O
and 33 36 3068 3071 O
men 37 40 3072 3075 O
must 41 45 3076 3080 O
be 46 48 3081 3083 O
willing 49 56 3084 3091 B-contraception_consent
to 57 59 3092 3094 I-contraception_consent
use 60 63 3095 3098 I-contraception_consent
adequate 64 72 3099 3107 I-contraception_consent
contraception 73 86 3108 3121 I-contraception_consent
during 87 93 3122 3128 O
the 94 97 3129 3132 O
entire 98 104 3133 3139 O
study 105 110 3140 3145 O
and 111 114 3146 3149 O
for 115 118 3150 3153 O
8 119 120 3154 3155 B-upper_bound
weeks 121 126 3156 3161 I-upper_bound
following 127 136 3162 3171 O
completion 137 147 3172 3182 O
of 148 150 3183 3185 O
all 151 154 3186 3189 O
chemotherapy 155 167 3190 3202 B-treatment
on 168 170 3203 3205 O
study 171 176 3206 3211 O
; 176 177 3211 3212 O
this 178 182 3213 3217 O
includes 183 191 3218 3226 O
hormonal 192 200 3227 3235 B-contraception_consent
or 201 203 3236 3238 O
barrier 204 211 3239 3246 B-contraception_consent
method 212 218 3247 3253 I-contraception_consent
, 218 219 3253 3254 O
or 220 222 3255 3257 O
abstinence 223 233 3258 3268 B-contraception_consent

breastfeeding 0 13 3269 3282 O
women 14 19 3283 3288 B-gender

metal 0 5 3289 3294 B-treatment
biliary 6 13 3295 3302 I-treatment
stents 14 20 3303 3309 I-treatment

